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Despite current guidelines, variability exists in the workup of
hypertensive children due to physician preferences. The
study evaluates primary vs secondary hypertension diagno-
sis from investigations routinely performed in hypertensive
children. This retrospective study included children 5 to
19 years with primary and secondary hypertension. The pro-
portions of abnormal laboratory and imaging tests were
compared between primary and secondary hypertension
groups. Risk factors for primary vs secondary hypertension
were evaluated by logistic regression and likelihood func-
tion analysis. Patients with secondary hypertension were
younger (5–12 years) and had a higher proportion of abnor-
mal creatinine, renal ultrasound, and echocardiogram find-
ings. There was no significant difference in abnormal results
of thyroid function, urine catecholamines, plasma renin, and
aldosterone. Abnormal renal ultrasound findings and age
were predictors of secondary hypertension by regression
and likelihood function analysis. Children aged 5 to 12 years
with abnormal renal ultrasound findings and high diastolic
blood pressures are at higher risk for secondary hypertension
that requires detailed evaluation. J Clin Hypertens (Greenwich).
2012; 14:316–321. 2012 Wiley Periodicals, Inc.
Increasing awareness of hypertension (HTN) has led
to heightened focus on pediatric HTN. Most children
are identified to have high blood pressures (BP) at
their pediatrician’s office during routine office visits.
Some of these patients are then referred to pediatric
subspecialists, mostly pediatric nephrologists, for the
evaluation and management of HTN.
Unlike in adults, secondary HTN due to an identifi-
able cause (most frequently renal or renovascular) is
more common in children.1–4 However, recent studies
have reported on the increasing incidence of primary
HTN in children.5–12 This changing landscape is due to
the increasing incidence of obesity and associated higher
BP trends in children.8 Routine measurement of BP on
well visits as recommended by the American Academy
of Pediatrics13 and longitudinal studies tracking high
BPs from adolescence into adulthood have also contrib-
uted to the increased focus on pediatric HTN.14,15 The
guidelines of the Fourth Report on the Diagnosis, Evalu-
ation, and Treatment of High Blood Pressure in Chil-
dren and Adolescents4 aim to stratify the workup of
high BP in children based on age, obesity, and severity
of HTN. The recommended routine workup for all chil-
dren with elevated BP includes serum urea nitrogen
(BUN), creatinine, electrolytes, urinalysis, urine culture,
complete blood cell count, renal ultrasonography
(USG), echocardiogram, and retinal examination.
According to these recommendations, children with
stage 2 HTN, very young children, and children and
adolescents with clinical signs that suggest systemic
conditions require more immediate and extensive evalu-
ation than children with stage 1 HTN. The extensive
evaluation may include renovascular imaging (techne-
tium dimercaptosuccinic acid [DMSA] scan, magnetic
resonance angiography, duplex Doppler flow, 3-dimen-
sional computerized axial tomography scan, and arteri-
ography), plasma renin activity (PRA), plasma and urine
steroid levels, and plasma and urine catecholamines.
The choice of these tests varies across practicing
physicians and is directed by personal preferences and
institutional protocol.6,16 This could be due to (1)
normal examination in most children with HTN,4 (2)
reviews and position papers recommending additional
workup based on clinical suspicion,4,17,18 (3) no
definite limit for age cutoff for identifying young
children,4,17,18 and (4) limited studies focusing on
evaluation of children with HTN.6,16
A study of various investigations performed in
hypertensive children may help practitioners to avoid
tests that are usually negative, leading to a more cost-
effective approach to children with elevated BP. The
current study, by evaluating the results of laboratory
and imaging tests done in asymptomatic children with
elevated BP, aims to identify factors that suggest
increased risk for primary vs secondary HTN.
METHODS
The study is a retrospective chart review of patients
found to have high BP at their pediatrician’s office and
then referred to the pediatric nephrology clinic at
Children’s Hospital of Michigan from January 2002
to December 2005. The study was approved by the
Human Investigation Committee at Wayne State
University and Research Review Committee at the
Detroit Medical Center.
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The study included children between the ages of 5
and 19 years who were diagnosed with primary or sec-
ondary HTN. We excluded patients with pre-existing
renal, cardiac, neurologic, and endocrine conditions
and patients taking medications associated with
elevated BP (corticosteroids, b-agonists, oral contra-
ceptives, and stimulant medications in patients with
attention deficit hyperactivity disorder). There were 9
patients who were excluded because of medications, 7
patients with neurological disorders, and 2 patients
with history of Takayasu arteritis.
Hypertension was defined as systolic and ⁄or dia-
stolic BP 95th percentile for age, sex, and height on
3 occasions.4 The BPs were measured after the
patient had been sitting quietly for at least 10 minutes,
initially by automated electronic device (Dinamap
200; General Electric Monitoring Systems, Wauke-
sha, WI) and then confirmed by auscultation. Systolic
BP was determined by the onset of the Korotkoff
sounds and diastolic BP by the disappearance of the
same. Stage 1 HTN was defined as per the Fourth
Task Force’s recommendations.4 Staging of HTN in
the patient population was performed retrospectively
based on the BP reading in the pediatric nephrology
clinic. Secondary HTN was defined as high BP second-
ary to an identifiable abnormality causing HTN such
as renal artery stenosis, renal scarring, hyperthyroid-
ism, coarctation of the aorta, or pheochromocytoma.
Primary HTN was a diagnosis of exclusion, given to
patients with high BP and normal investigations in the
workup for secondary causes.
Evaluation of patients consisted of a complete his-
tory and physical examination. Data collected included
age, sex, family history of HTN, symptoms associated
with HTN, and body mass index (BMI). z Scores were
calculated for systolic BP, diastolic BP, and BMI to
estimate level of BP elevation and degree of adiposity.
Family history was considered positive if at least one
parent had a history of HTN. The workup for children
with elevated BP included complete blood cell count,
electrolytes, BUN, creatinine, PRA, serum aldosterone,
thyroid function tests (TFTs) including free thyroxine
and thyroid-stimulating hormone; urinalysis, and spot
urine catecholamines. Spot urine catecholamines
included urine vanillylmandelic acid and homovanillic
acid, measured with the use of high-performance
liquid chromatography. Imaging studies consisted of a
renal USG, echocardiogram, and DMSA scan. Echo-
cardiography was considered abnormal if there was
left ventricular hypertrophy (LVH). USG showing sin-
gle kidneys, asymmetric renal size (size difference in
the 2 kidneys of 1.5 cm), increased echogenicity,
renal or perirenal mass, congenital anomalies including
cysts, duplication, or ectopia were grouped as abnor-
mal for data analysis.
SPSS (version 18.0; SPSS, IBM, Armonk, NY) was
used for statistical analysis. Chi-square test was used
to compare the frequency of normal vs abnormal
results of BMI; blood, urine, and imaging tests; and
presence of family history and symptoms between
patients with primary and secondary HTN. Mann-
Whitney test was used to compare age means as well
as z score means since the distribution was not normal
(based on Kolmogorov-Smirnov test).
A binary logistic regression analysis was performed
to identify independent variables associated with an
increased risk for a diagnosis of primary or secondary
HTN (dependent variable). Odds ratios (ORs) calcu-
lated by logistic regression analysis were analyzed and
variables with ORs >1 and P<.05 were associated
with increased risk for a diagnosis of secondary HTN.
Unlike logistic regression analysis, likelihood function
analysis is not affected by sample size as compared
with OR obtained via binary logistic regression.19
Therefore, this statistical analysis was also performed
to evaluate the prediction of primary and secondary
HTN from normal and abnormal results of the labora-
tory and imaging investigations. Likelihood ratios
(LRs) function using statistical methods based on the
Law of Likelihood, which is fundamental to the gen-
eral issue of interpreting statistical data as evidence.
Based on the approach referred as ‘‘The Evidential
Paradigm,’’ it provides a fundamental structure for
presenting and evaluating LRs as measures of statisti-
cal evidence for one hypothesis over another. LRs
were interpreted as follows: ratios between 1 and
8 = weak evidence, between 8 and 32 = moderate
evidence, and >32 = strong evidence.19
RESULTS
There were 167 patients included in the study: 110
with primary HTN and 57 with secondary HTN. Pri-
mary HTN accounted for 55% (n=36) of the patients
in the 5- to 12-year age group. Patients with secondary
HTN (5–19 years; n=57) included 45 patients (78.9%)
with renal scarring, 7 patients (12.3%) with renal
artery stenosis, and 1 patient (1.8%) each with a sin-
gle kidney, aortic coarctation, juxtaglomerular tumor,
pheochromocytoma, and hyperthyroidism.
The demographics, family history, symptoms, and
HTN stages for the 167 patients are shown in Table I.
The majority of patients with primary HTN were male
(69.1%), whereas those with secondary HTN had a
slight female predominance (54.4%) (P<.01). Patients
with primary HTN were older (13.33.23 years) than
patients with secondary HTN (11.73.57 years)
(P<.01). The overall mean age of the patients was
12.79 years (3.43). A higher proportion of children
with primary HTN had a positive family history of
HTN (P=.01), stage 1 HTN (P=.03), and older age
group (12–19 years) (P=.02) on presentation. Of note,
frequency of overweight and obese children did not
differ in the primary (75.5%) vs secondary (61.4%)
HTN groups (P=.73).
Table II shows a comparison of z scores for systolic
and diastolic BP, as well as BMI between patients with
primary and secondary HTN according to age group.
Patients with secondary HTN who were in the older
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age group had significantly higher diastolic BP z scores
as compared with older patients with primary HTN.
As seen in Table III, abnormal creatinine (P=.01),
abnormal electrolytes (P=.04), USG (P<.01), and
echocardiography (P=.03) were significantly higher in
children with secondary HTN, while abnormal results
on other laboratory tests did not show significant dif-
ferences between the primary and secondary HTN
groups. Patients with primary HTN with abnormal
PRA had detailed investigations such as magnetic reso-
nance imaging ⁄angiography, DMSA scan, or renal
arteriography to rule out renovascular causes of ele-
vated BP. The one patient in this group who had
abnormal spot urine catecholamines had 24-hour urine
for catecholamines performed, which showed normal
results. The two patients with abnormal urinalysis
(proteinuria) were treated as having primary HTN for
the study duration. However, these patients later
developed overt nephritis and were therefore excluded
from regression and z score analysis.
Results of USG are displayed in Table IV. Some
patients with primary HTN had abnormal USG find-
ings, which included asymmetry, simple cysts, duplica-
tion of collecting system, and increased echogenicity.
The patient who had renal asymmetry had a DMSA
scan performed, which did not show any scarring,
and arteriography, which was normal. The details of
the results of renal imaging of some of the patients
were not available as they were performed at other
institutions.
ORs calculated by logistic regression showed an
increased risk for diagnosing secondary HTN associ-
ated with young age (5–11.9 years), elevated diastolic
BP in older patients, and abnormal USG. Hypertension
stage, BMI, family history, echocardiography, and sys-
tolic BP did not have statistically significant risk for
diagnosing secondary HTN. Similar results were seen
with LR analysis. LR for abnormal USG results
TABLE I. Demographics, Family History, Symptoms,
and Hypertension Stages in Patients With Primary
and Secondary HTN
Primary HTN
(n=110)
Secondary
HTN (n=57) P Value
Age, mean (SD), y 13.3 (3.23) 11.7 (3.57) <.01
Age 5–12 y, No. (%) 36 (32.7) 30 (52.6) .02
Age 12–19 y, No. (%) 74 (67.3) 27 (47.4)
Male, No. (%) 76 (69.1) 26 (45.6) <.01
Female, No. (%) 34 (30.9) 31 (54.4)
African American, No. (%) 71 (64.5) 35 (61.4)
Caucasian, No. (%) 32 (29.1) 19 (33.3)
Other, No. (%) 7 (6.4) 3 (5.3)
Positive family history of
HTN, No. (%)
45 (42.1) 11 (19.6) .01
Headache, No. (%) 35 (31.8) 21 (36.8) .60
Vision changes, No. (%) 2 (1.8) 2 (1.8) 1.00
BMI 85th percentile,
No. (%)
83 (75.5) 35 (61.4) .73
HTN stage 1, No. (%) 54 (49.1) 18 (31.6) .03
HTN stage 2, No. (%) 56 (50.9) 39 (68.4)
Abbreviations: BMI, body mass index; HTN, hypertension; SD, stan-
dard deviation.
TABLE II. Comparison of z Scores of SBP, DBP,
and BMI Between Patients With Primary and
Secondary HTN
Primary HTN,
Mean (SD)
Secondary
HTN, Mean (SD) P Value
SBP
Age 5–11.9 y )0.41 (0.84) )0.11 (1.06) NS
Age 12–19 y 0.04 (0.80) 0.56 (1.33) NS
DBP
Age 5–11.9 y )0.26 (0.98) 0.09 (1.23) NS
Age 12–19 y )0.16 (0.72) 0.67 (1.13) .001
BMI
Age 5–11.9 y )0.12 (0.92) )0.51 (0.81) NS
Age 12–19 y )0.28 (1.08) )0.04 (0.84) NS
Abbreviations: BMI, body mass index; DBP, diastolic blood pres-
sure; HTN, hypertension; NS, not significant; SBP, systolic blood
pressure; SD, standard deviation.
TABLE III. Frequency of Abnormal Results on
Laboratory and Imaging Tests in Patients With
Primary and Secondary Hypertension
Primary
Hypertension
(n=110),
No. (%)
Secondary
Hypertension
(n=57),
No. (%) P Value
Electrolytes 0 (0) 3 (5.4) .04
Creatinine 0 (0) 4 (7.0) .01
Thyroid function tests 0 (0) 2 (4.3) .11
Plasma renin activity 10 (13.3) 9 (23.1) .19
Aldosterone 0 (0) 2 (5.6) .10
Spot urine catecholamines 1 (1.5) 2 (5.1) .56
Urinalysis 2 (1.9) 3 (5.4) .34
Renal ultrasonography 10 (10.2) 19 (34.5) .001
Echocardiography 16 (17.2) 16 (34.0) .03
TABLE IV. Renal Ultrasound Findings in Primary and
Secondary Hypertension
Primary
(n=99)
Secondary
(n=54)
Normal 88 36
Asymmetry 1 8
Congenital anomalies
Simple cysts 1 1
Duplication of collecting system 4 2
Ectopia 0 1
Increased echogenicity 4 4
Single kidney 0 1
Renal or perirenal mass 0 2
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(LR=742) showed strong statistical evidence (LR >32),
while LR for young age (LR=22.9) showed moderate
statistical evidence for diagnosing secondary HTN
(Table V).
DISCUSSION
Hypertension is one of the most commonly diagnosed
medical conditions in the United States.20 Given the
significant long-term complications of uncontrolled BP
and tracking of BP from childhood to adults, evalua-
tion and management of children with elevated BP has
significant clinical and financial implications. This is
because unlike adults, children usually undergo a more
extensive workup to look for secondary causes of
HTN.21
Our study cohort consisted of otherwise healthy
children aged 5 to 19 years with elevated BP referred
to a pediatric nephrology clinic for evaluation, who,
after a detailed evaluation, were diagnosed with either
primary or secondary HTN. These patients in the
authors’ opinion were representative of the growing
patient population in whom health care providers need
to increasingly decide about investigations to evaluate
secondary causes of HTN. The study aimed at evaluat-
ing the clinically relevant information obtained from
various tests (laboratory and imaging) peformed to dif-
ferentiate secondary vs primary HTN in asymptomatic
children with elevated BP readings. This would help in
streamlining the evaluation of increasing number of
children with elevated BP and avoiding tests with
negative results, with resulting cost benefits in the
workup of these patients.
The Fourth Task Force Report recommends stratify-
ing evaluation of children with elevated BP, based on
classification of HTN as stage 1 or 2, ‘‘young age,’’
and whether the children are overweight or not.4 The
current study reports increased risk for secondary
HTN in children younger than 12 years. This adds
important information to the Task Force recommenda-
tions as there is no definition for ‘‘young age’’ in the
report. Furthermore, nearly 51% of the patients with
primary HTN had stage 2 HTN at presentation and,
based on the recommendations of the Task Force
Report, would qualify for extensive evaluation with
questionable relevance to clinical management.
A recent study evaluating investigations performed
for workup of HTN across 4 tertiary pediatric
nephrology centers reported that BUN, serum
creatinine, electrolytes, and urinalysis were the most
common laboratory tests performed in patients with
primary HTN; other investigations such as PRA,
serum aldosterone, USG, urine catecholamines, and
DMSA scan varied across centers.6 Another study, per-
formed after the Fourth Task Force Report of 2004,
surveyed general pediatricians regarding the evaluation
and treatment of HTN and reported that >50% of
pediatricians order chemistry panel, urinalysis,
complete blood cell count, lipid panel, and TFT for
evaluation of children with HTN, while <10%
ordered an echocardiogram.16 This variability in the
evaluation of children with elevated BP, although
reflective of the prevalent practice patterns, is also a
limitation of the current study.
In keeping with the recommendations of the Fourth
Task Force Report, a USG should be performed in all
patients with elevated BP. However, the use of USG in
evaluating children with primary HTN ranged from
25% to 95% in a multicenter study involving 4 ter-
tiary care centers.6 Another study also reported that a
routine USG was ordered by only 20% of the pediatri-
cians for children with elevated BP.16 Identification of
asymmetry of the kidneys (>1.5 cm difference in
length), single kidney, or a renal or perirenal mass
were the relevant findings identified in patients with
secondary HTN (Table IV). USG, although not a good
imaging modality for detecting renal scars,22,23 can
potentially identify the need for further imaging. Find-
ings such as small kidney size or asymmetry of the
kidneys should prompt further investigations such as
DMSA, which is more accurate for identification of
renal scarring.24 In our group of patients with second-
ary HTN, renal scarring was the most common cause
of HTN. Renal scarring is considered a common sec-
ondary cause of HTN in children.23,25 In our opinion,
DMSA is a useful investigation in children with HTN
and should be considered in patients younger than
12 years, patients with history of urinary tract infec-
tions, and children with abnormal USG findings.
In the older age group (12–19 years old), z scores
for diastolic BP were found to be significantly higher
in patients with secondary HTN (Table II). This is
consistent with previous reports that have found that
children with secondary causes of HTN have higher
diastolic BPs compared with children with primary
HTN.26
In our study, the frequency of abnormal values of
TFT, serum aldosterone, spot urine catecholamines,
and urinalysis was low and not statistically different
between patients with primary and secondary HTN.
The frequency of abnormal values of these tests was
compared between patients with stage 1 and stage 2
TABLE V. HTN Factors Associated With Increased
Risk of Secondary
Variable
Logistic
Regression
Likelihood
Function
Analysis
OR (95% CI) P Value LR
Abnormal RUS findings 4.89 (1.99–12.01) .001 742.9
DBP z scorea 3.33 (1.49–7.46) .003 –
Young age (5–11.9 y) 2.22 (1.09–4.53) .03 22.9
Abbreviations: DBP, diastolic blood pressure; OR, odds ratio (OR >1
and P<.05 statistically significant); LR, likelihood ratio (between 1
and 8 = weak evidence, between 8 and 32 = moderate evidence,
and >32 = strong evidence); RUS, renal ultrasound. aFor the 12- to
19-year-old age group.
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HTN and there was also no difference (data not
shown). The yield of investigations such as urine cate-
cholamines and TFT is low in otherwise healthy
asymptomatic children with HTN and should be pe-
formed when there is a clinical suspicion of these con-
ditions. Both pheochromocytoma and hyperthyroidism
are more likely to present with obvious clinical signs
and symptoms in addition to high BP. Spot urine cate-
cholamines have been reported to be as effective as
24-hour urine collections for the diagnosis of neuro-
blastoma.27 Pheochromocytoma, on the other hand,
usually presents with other signs of disease such as
episodes of palpitations, dizziness, and flushing, and,
without a strong clinical suspicion, urine catechol-
amine testing is not useful for diagnosis.28
In the initial workup of asymptomatic apparently
healthy children who present with HTN, we recom-
mend checking electrolytes and renal function. Base-
line values of these tests are helpful when starting
antihypertensive medications such as angiotensin-
converting enzyme inhibitors and thiazide diuretics,
which can affect these tests. A urinalysis should also
be part of the workup since proteinuria can be present
in long-standing uncontrolled HTN, indicating end
organ damage, and in renal scarring.
Presence of LVH on echocardiography was signifi-
cantly more common in patients with secondary HTN;
however, patients with LVH did not have an increased
risk of secondary HTN in the binary logistic regression
or likelihood function analysis.
Despite 16.7% of study patients having abnormal
PRA values, the frequency of abnormal PRA did not dif-
fer significantly between primary and secondary HTN
groups. Furthermore, detailed renovascular imaging
including arteriogram was performed in these patients
to rule out renovascular causes of HTN. Although PRA
is not helpful to distinguish between primary and sec-
ondary HTN according to our results, it could be useful
for tailoring antihypertensive treatment. Laragh and
colleagues proposed that hypertensive patients with ele-
vated PRA are better candidates for antihypertensive
agents that target the renin angiotensin system (angio-
tensin-converting enzyme inhibitors or angiotensin
receptor blockers),29,30 as opposed to patients with sup-
pressed PRA secondary to sodium and volume excess
who would respond better to diuretic therapy.
The current practice of most pediatric health care
providers is to routinely order a panel of blood tests
and imaging studies in the initial evaluation of a
hypertensive patient based on personal preferences and
institutional protocols. In keeping with the principles
of the Fourth Task Force Report,4 the current study is
an attempt to stratify the workup of children with ele-
vated BP. We agree with the recommendations of the
Task Force in including electrolytes, BUN, creatinine,
USG, and echocardiogram in all children with elevated
BP. The Task Force makes no recommendation to the
age of children who require detailed investigations4;
however, according to our study, children aged 5 to
12 years with an initially abnormal USG finding are at
high risk for secondary HTN and require a more
detailed evaluation. The study reports for the first time
that routine spot urine catecholamines and TFT pro-
vide little information in asymptomatic children with
elevated BP, even in children presenting with stage 2
HTN, and their use should be restricted to patients
with relevant clinical findings. Although limited by its
retrospective nature, our study findings provide a start-
ing framework for pediatric health care providers
for children with elevated BP in the office setting. The
study findings may help in providing a more cost-
effective approach towards children with elevated BP,
until prospective studies focusing on evaluation of
asymptomatic children with elevated BP are conducted.
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